3.6.5.4 Abortion, Spontaneous http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15105393&form=6&db=m Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. causal interaction,diagnostic usage,therapeutic application,unassigned 2,1,1,0 3.6.5.4 Adenomatous Polyposis Coli http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1651174&form=6&db=m Identification and characterization of the familial adenomatous polyposis coli gene. unassigned - 3.6.5.4 Adenoviridae Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8932367&form=6&db=m Monomeric scAlu and nascent dimeric Alu RNAs induced by adenovirus are assembled into SRP9/14-containing RNPs in HeLa cells. unassigned - 3.6.5.4 Colitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9449719&form=6&db=m Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. ongoing research,unassigned 3,0 3.6.5.4 Colitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16735026&form=6&db=m Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice. ongoing research,unassigned 3,0 3.6.5.4 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11845260&form=6&db=m The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation. diagnostic usage,ongoing research,unassigned 4,3,0 3.6.5.4 Congenital Bone Marrow Failure Syndromes http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28972538&form=6&db=m Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. causal interaction,ongoing research,unassigned 2,2,0 3.6.5.4 Connective Tissue Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19089533&form=6&db=m Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,3,0 3.6.5.4 Connective Tissue Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26192196&form=6&db=m Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. causal interaction,therapeutic application,unassigned 3,4,0 3.6.5.4 Connective Tissue Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27665513&form=6&db=m Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,1 3.6.5.4 Cryptogenic Organizing Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19639324&form=6&db=m Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP). unassigned - 3.6.5.4 Dehydration http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16339937&form=6&db=m Cloning and characterization of the goadsporin biosynthetic gene cluster from Streptomyces sp. TP-A0584. unassigned - 3.6.5.4 Dermatomyositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9857079&form=6&db=m The 72-kDa component of signal recognition particle is cleaved during apoptosis. causal interaction,unassigned 1,0 3.6.5.4 DiGeorge Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29956078&form=6&db=m Severe Congenital Neutropenia associated with SRP54 mutation in 22q11.2 Deletion Syndrome: Hematopoietic Stem Cell Transplantation Results in Correction of Neutropenia with Adequate Immune Reconstitution. causal interaction,unassigned 3,0 3.6.5.4 Gingival Overgrowth http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10444742&form=6&db=m Signal recognition particle receptor (SRPR) is downregulated in a rat model of cyclosporin A-induced gingival overgrowth. ongoing research,unassigned 3,0 3.6.5.4 Hepatitis C http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21509787&form=6&db=m Automated RNA tertiary structure prediction from secondary structure and low-resolution restraints. unassigned - 3.6.5.4 Hypercholesterolemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11535595&form=6&db=m Inhibition of protein translocation across the endoplasmic reticulum membrane by sterols. therapeutic application,unassigned 1,0 3.6.5.4 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21149457&form=6&db=m Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania. causal interaction,ongoing research,therapeutic application,unassigned 3,2,4,0 3.6.5.4 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28086075&form=6&db=m Cellular microRNA miR-10a-5p inhibits replication of porcine reproductive and respiratory syndrome virus by targeting the host factor signal recognition particle 14. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.6.5.4 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29465613&form=6&db=m What is in the Myopathy Literature? causal interaction,ongoing research,unassigned 3,3,0 3.6.5.4 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33080218&form=6&db=m SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. diagnostic usage,ongoing research,unassigned 2,2,0 3.6.5.4 Kidney Failure, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11124592&form=6&db=m Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis. diagnostic usage,ongoing research,unassigned 1,3,0 3.6.5.4 Latent Infection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34194479&form=6&db=m The RNA-Binding Proteins SRP14 and HMGB3 Control HIV-1 Tat mRNA Processing and Translation During HIV-1 Latency. unassigned - 3.6.5.4 Leukemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10437986&form=6&db=m Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. ongoing research,unassigned 1,0 3.6.5.4 Leukemia, Myeloid, Acute http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33985510&form=6&db=m Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,3,0 3.6.5.4 Lupus Erythematosus, Systemic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7604300&form=6&db=m Autoantibodies in the diagnosis of systemic rheumatic diseases. diagnostic usage,unassigned 1,0 3.6.5.4 Lupus Erythematosus, Systemic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9857079&form=6&db=m The 72-kDa component of signal recognition particle is cleaved during apoptosis. causal interaction,unassigned 1,0 3.6.5.4 Lupus Nephritis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25883715&form=6&db=m Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management. therapeutic application,unassigned 1,0 3.6.5.4 Lymphopenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33305263&form=6&db=m Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. ongoing research,therapeutic application,unassigned 2,1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12235311&form=6&db=m Myopathy with antibodies to the signal recognition particle: clinical and pathological features. diagnostic usage,ongoing research,therapeutic application,unassigned 4,1,2,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16616848&form=6&db=m Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP). therapeutic application,unassigned 1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21763952&form=6&db=m Anti-signal recognition particle myopathy in the first decade of life. causal interaction,diagnostic usage,unassigned 3,4,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21794664&form=6&db=m [Histological and molecular alterations in inflammatory myopathies]. therapeutic application,unassigned 4,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22246873&form=6&db=m Necrotizing myopathy: clinicoserologic associations. unassigned - 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22332183&form=6&db=m Myopathy Associated With Antibodies to Signal Recognition Particle: Disease Progression and Neurological Outcome. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,4,1,1 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22436377&form=6&db=m A pediatric patient with myopathy associated with antibodies to a signal recognition particle. causal interaction,unassigned 4,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22955022&form=6&db=m Myositis autoantibodies. unassigned - 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22998975&form=6&db=m [Acquired necrotizing myopathies.] causal interaction,therapeutic application,unassigned 3,2,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24041831&form=6&db=m Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). unassigned - 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25203117&form=6&db=m Necrotizing myopathies: beyond statins. unassigned - 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25342013&form=6&db=m [A case of an anti-SRP myopathy with enlargement of the thymus]. causal interaction,unassigned 3,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25417246&form=6&db=m Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25883715&form=6&db=m Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management. therapeutic application,unassigned 1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25904255&form=6&db=m [A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia]. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,1,3 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26240092&form=6&db=m Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide. diagnostic usage,therapeutic application,unassigned 3,3,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26312949&form=6&db=m Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases. causal interaction,diagnostic usage,unassigned 2,3,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27111848&form=6&db=m Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. ongoing research,unassigned 2,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27147697&form=6&db=m Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. causal interaction,unassigned 1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27916753&form=6&db=m [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective]. causal interaction,unassigned 4,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29089059&form=6&db=m Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,2,1 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29465613&form=6&db=m What is in the Myopathy Literature? causal interaction,ongoing research,unassigned 3,3,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31922478&form=6&db=m Immune-mediated necrotizing myopathy associated with antibodies to the signal recognition particle: A rare cause of hyperCKaemia. causal interaction,unassigned 1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32666706&form=6&db=m Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy. therapeutic application,unassigned 1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33305263&form=6&db=m Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. ongoing research,therapeutic application,unassigned 2,1,0 3.6.5.4 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33786066&form=6&db=m Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series. causal interaction,diagnostic usage,therapeutic application,unassigned 1,1,1,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7725809&form=6&db=m [Diagnostic significance of scleroderma and myositis-associated autoantibodies] diagnostic usage,unassigned 2,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12235311&form=6&db=m Myopathy with antibodies to the signal recognition particle: clinical and pathological features. diagnostic usage,ongoing research,therapeutic application,unassigned 4,1,2,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16651706&form=6&db=m [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis] causal interaction,therapeutic application,unassigned 2,1,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16901077&form=6&db=m Myositis specific autoantibodies. causal interaction,unassigned 2,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19639324&form=6&db=m Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP). unassigned - 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21191666&form=6&db=m Cutting Edge Issues in Polymyositis. therapeutic application,unassigned 1,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21794664&form=6&db=m [Histological and molecular alterations in inflammatory myopathies]. therapeutic application,unassigned 4,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22246873&form=6&db=m Necrotizing myopathy: clinicoserologic associations. unassigned - 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23591825&form=6&db=m Autoantibodies in polymyositis and dermatomyositis. therapeutic application,unassigned 1,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26312949&form=6&db=m Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases. causal interaction,diagnostic usage,unassigned 2,3,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27111848&form=6&db=m Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. ongoing research,unassigned 2,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27224441&form=6&db=m What's in the Literature? diagnostic usage,unassigned 1,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27607340&form=6&db=m Spectrum of immune-mediated necrotizing myopathies and their treatments. unassigned - 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27916753&form=6&db=m [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective]. causal interaction,unassigned 4,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29089059&form=6&db=m Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,1,2,1 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29465613&form=6&db=m What is in the Myopathy Literature? causal interaction,ongoing research,unassigned 3,3,0 3.6.5.4 Myositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32666706&form=6&db=m Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy. therapeutic application,unassigned 1,0 3.6.5.4 Myositis, Inclusion Body http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29465613&form=6&db=m What is in the Myopathy Literature? causal interaction,ongoing research,unassigned 3,3,0 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11845260&form=6&db=m The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation. diagnostic usage,ongoing research,unassigned 4,3,0 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15742198&form=6&db=m The moving parts of the nucleolus. unassigned - 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15949261&form=6&db=m [Detection of gene expression alteration of myeloma cells treated with arsenic trioxide] unassigned - 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19114010&form=6&db=m Genomic selection of reference genes for real-time PCR in human myocardium. unassigned - 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21438832&form=6&db=m Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry. unassigned - 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26192196&form=6&db=m Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. causal interaction,therapeutic application,unassigned 3,4,0 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27665513&form=6&db=m Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,1,1 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28099331&form=6&db=m Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. diagnostic usage,unassigned 4,0 3.6.5.4 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33985510&form=6&db=m Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia. causal interaction,diagnostic usage,ongoing research,unassigned 3,4,3,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28972538&form=6&db=m Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. causal interaction,ongoing research,unassigned 2,2,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29914977&form=6&db=m Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome. causal interaction,unassigned 4,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29956078&form=6&db=m Severe Congenital Neutropenia associated with SRP54 mutation in 22q11.2 Deletion Syndrome: Hematopoietic Stem Cell Transplantation Results in Correction of Neutropenia with Adequate Immune Reconstitution. causal interaction,unassigned 3,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30237254&form=6&db=m SRP54 and a need for a new neutropenia nosology. therapeutic application,unassigned 4,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32277798&form=6&db=m Congenital neutropenia with variable clinical presentation in novel mutation of the SRP54 gene. causal interaction,ongoing research,unassigned 4,2,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32623377&form=6&db=m Three patients with glucose-6 phosphatase catalytic subunit 3 deficiency. causal interaction,unassigned 3,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33053321&form=6&db=m Structural and Functional Impact of SRP54 Mutations Causing Severe Congenital Neutropenia. causal interaction,unassigned 4,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33227812&form=6&db=m SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing. causal interaction,ongoing research,therapeutic application,unassigned 3,3,1,0 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33417891&form=6&db=m Cellular Traffic Jam and Disease Due to Mutations in SRP54. unassigned - 3.6.5.4 Neutropenia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33839879&form=6&db=m A Filipino infant with severe neutropenia owing to SRP54 mutations was successfully treated with ethnically mismatched cord blood transplantation from a Japanese cord blood bank. therapeutic application,unassigned 1,0 3.6.5.4 Pneumonia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19639324&form=6&db=m Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP). unassigned - 3.6.5.4 Polymyositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2403400&form=6&db=m Antibody to signal recognition particle in polymyositis. ongoing research,unassigned 2,0 3.6.5.4 Polymyositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18322984&form=6&db=m Autoantibody to signal recognition particle in African American girls with juvenile polymyositis. unassigned - 3.6.5.4 Polymyositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27916753&form=6&db=m [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective]. causal interaction,unassigned 4,0 3.6.5.4 Polymyositis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29396013&form=6&db=m Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient. causal interaction,therapeutic application,unassigned 3,1,0 3.6.5.4 Porcine Reproductive and Respiratory Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28086075&form=6&db=m Cellular microRNA miR-10a-5p inhibits replication of porcine reproductive and respiratory syndrome virus by targeting the host factor signal recognition particle 14. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,3,0 3.6.5.4 Scleroderma, Systemic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7604300&form=6&db=m Autoantibodies in the diagnosis of systemic rheumatic diseases. diagnostic usage,unassigned 1,0 3.6.5.4 Shwachman-Diamond Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30198570&form=6&db=m Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations. unassigned - 3.6.5.4 Shwachman-Diamond Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33053321&form=6&db=m Structural and Functional Impact of SRP54 Mutations Causing Severe Congenital Neutropenia. causal interaction,unassigned 4,0 3.6.5.4 Shwachman-Diamond Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33227812&form=6&db=m SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing. causal interaction,ongoing research,therapeutic application,unassigned 3,3,1,0 3.6.5.4 signal-recognition-particle gtpase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33227812&form=6&db=m SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing. causal interaction,ongoing research,therapeutic application,unassigned 3,3,1,0 3.6.5.4 Spina Bifida Cystica http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22108047&form=6&db=m Proteomic analysis of amniotic fluid of pregnant rats with spina bifida aperta. unassigned - 3.6.5.4 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29361248&form=6&db=m Characterization of FtsY, its interaction with Ffh, and proteomic identification of their potential substrates in Mycobacterium tuberculosis. ongoing research,unassigned 2,0 3.6.5.4 Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33412199&form=6&db=m Essential biochemical, biophysical and computational inputs on efficient functioning of Mycobacterium tuberculosis H37Rv FtsY. ongoing research,unassigned 1,0